Performance
No data available
Scheme Returns (%) | |
Benchmark Returns (%)# | |
Additional Benchmark Returns (%)## | |
Value of Investment of Rs 10,000 | |
Scheme Returns (Rs.) | |
Benchmark (Rs.)# | |
Additional Benchmark (Rs.)## |
- ^Past performance may or may not be sustained in future and is not a guarantee of any future returns. # BSE Healthcare Index TRI #...Read More
Fund Managers
Mr. Nikhil Mathur
Fund Manager and Senior Equity Analyst
OVERSEAS
Mr. Dhruv Muchhal
Equity Analyst and Fund Manager for Overseas Investments
Top 10 Holdings
As on 30 Jun 2025
Downloads
HDFC Pharma and Healthcare Fund
Product Labelling

Benchmark Riskometer
This product is suitable for investors who are seeking~
- To generate long-term capital appreciation
- Investment predominantly in equity & equity related instruments of Pharma and healthcare companies
~Investors should consult their financial advisers, if in doubt about whether the product is suitable for them.
The Scheme being sectoral in nature carries higher risks versus diversified equity mutual funds on account of concentration and sector specific risks.